ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Concepts For New Trials In Imaging, Intraoperative RT

June 14, 1985

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Richard Pazdur’s Comments to ODAC

July 22, 2011

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988